MediVet Equine

SGF-1000 Salesman Kegley Gets 30 Months in Prison

Michael Kegley, Jr., the former sales director for the company that sold the purportedly performance-enhancing drug (PED) SGF-1000 that is at the heart of a years-long investigation of an international racehorse doping conspiracy, got sentenced to 30 months in prison on Thursday. Kegley, 41, had pleaded guilty in July 2021 to one count of drug adulteration and misbranding. He had admitted in open court at that time that as sales director for the Kentucky-based MediVet Equine, he sold SGF-1000 and other products to trainers and veterinarians, knowing that there was...

[ Read More ]
Max Prison Sentence for Vet Rhein

Kristian Rhein, a suspended veterinarian formerly based at Belmont Park who was caught on a wiretap bragging that he sold "assloads" of SGF-1000 to racehorse trainers, was sentenced to three years imprisonment Wednesday after pleading guilty to one felony charge within the federal government's sprawling prosecution of an allegedly years-long conspiracy to dope racehorses. Judge Mary Kay Vyskocil imposed the maximum-allowable prison term under federal sentencing guidelines Jan. 5 in United States District Court (Southern District of New York). According to the court order filed in conjunction with his sentencing,...

[ Read More ]
Vet Who Allegedly Bragged About Selling PEDs to Change Plea

Kristian Rhein, a veterinarian formerly based at Belmont Park whom federal prosecutors allegedly have on tape bragging that he sold "assloads" of the illegal performance-enhancing drug SGF-1000, has been granted an Aug. 3 change-of-plea hearing at which he is expected to alter his initial "not guilty" plea in the highly publicized racehorse doping scandal. Rhein was allegedly part of a "widespread, corrupt scheme" dating to at least 2017 that allegedly involved the now-barred trainers Jorge Navarro and Jason Servis, plus a vast network of co-conspirators who allegedly manufactured, mislabeled, rebranded,...

[ Read More ]
X

Never miss another story from the TDN

Click Here to sign up for a free subscription.